ANIXA BIOSCIENCES, INC. (ANIX)

Every figure this model derived for ANIX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-10-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2020-10-31
cash 13,686,000 CashAndCashEquivalentsAtCarryingValue 2026-04-30
current assets 14,692,000 AssetsCurrent 2026-04-30
current liabilities 1,501,000 LiabilitiesCurrent 2026-04-30
equity 14,475,000 StockholdersEquity 2026-04-30
revenue 210,000 Revenues 2024-10-31
sbc 0 ShareBasedCompensation 2026-04-30

The ratios

The figures themselves rather than their scores — what somebody looking up ANIX on one particular measure came for.

RatioValue
current ratio9.79
current ratio reported9.79
deferred revenue growth0.0
dilution pct1.74
growth cv3.05
revenue growth0.0
revenue growth per share-1.71
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about ANIX's figures. Written by the derivation as it ran, not added afterwards.